Pulmonary & Respiratory Medicine

Cystic Fibrosis (CF) is a genetic disorder that primarily affects the lungs and digestive system. It is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, which leads to the production of thick, sticky mucus that can clog the airways and obstruct the pancreas. This result in respiratory symptoms such as chronic coughing, frequent lung infections, and difficulty breathing, as well as digestive issues such as poor growth, difficulty gaining weight, and malabsorption of nutrients. CF is a lifelong condition with no cure, but treatment aims to manage symptoms, prevent complications, and improve quality of life. Therapies may include medications to thin mucus, antibiotics to treat infections, nutritional support, airway clearance techniques, and lung transplant in severe cases. Early diagnosis and comprehensive care from a multidisciplinary team of healthcare professionals can help individuals with CF live longer and healthier lives.

Eosinophilic lung diseases encompass a group of conditions characterized by the accumulation of eosinophils in the lungs, leading to inflammation and tissue damage. These diseases can be broadly categorized into eosinophilic pneumonia, Eosinophilic Granulomatosis with Polyangiitis (EGPA), and Hypereosinophilic Syndrome (HES). Eosinophilic pneumonia includes acute and chronic forms, with symptoms such as cough, dyspnea, fever, and infiltrates on chest imaging. Causes may include infections, medications, or environmental exposures. EGPA, formerly known as Churg-Strauss syndrome, is a rare autoimmune condition characterized by asthma, eosinophilia, and systemic vasculitis affecting small to medium-sized blood vessels. It can involve multiple organs, including the lungs, leading to respiratory symptoms, such as cough, wheezing, and infiltrates on imaging. HES is a heterogeneous disorder characterized by persistent eosinophilia and organ damage. Lung involvement may manifest as cough, dyspnea, infiltrates, or fibrosis. Diagnosis of eosinophilic lung diseases involves clinical evaluation, laboratory tests (including blood eosinophil count), imaging studies (such as chest X-ray or CT scan), and sometimes lung biopsy. Treatment depends on the underlying cause and severity of the disease but often includes corticosteroids to reduce inflammation and suppress eosinophil activity. Other immunosuppressive agents may be used in refractory cases. Management may also involve treating underlying conditions, such as asthma or parasitic infections, and avoiding triggers, such as allergens or certain medications. Close monitoring and follow-up are essential to assess treatment response and disease progression.

The lungs, as vital organs responsible for oxygen exchange and removal of carbon dioxide, are constantly exposed to a plethora of pathogens present in the environment. These pathogens, ranging from bacteria and viruses to fungi and parasites, have the potential to cause a wide spectrum of respiratory infections, ranging from mild, self-limiting illnesses to severe, life-threatening diseases. Understanding the characteristics, epidemiology, clinical manifestations, diagnostic approaches, and management strategies associated with common lung pathogens is crucial for effective prevention, diagnosis, and treatment of respiratory infections. In this comprehensive exploration, we delve into the intricacies of some of the most prevalent lung pathogens, shedding light on their impact on respiratory health and the challenges they pose to healthcare systems worldwide.

Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. It affects people of all ages, but often begins in childhood. Triggers such as allergens, respiratory infections, exercise, and environmental factors can exacerbate symptoms. Diagnosis involves a combination of medical history, physical examination, and lung function tests. Treatment typically includes inhaled corticosteroids to reduce inflammation, bronchodilators to relieve symptoms, and avoidance of triggers. With proper management, most individuals with asthma can lead active lives with minimal symptoms. However, severe asthma cases may require additional medications and specialized care.